Novartis to buy US gene therapy group AveXis for $8.7 bn

Swiss pharmaceuticals giant Novartis announced Monday it will buy US gene therapy company AveXis for $8.7 billion (7.1 billion euros).
Sourve

More Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: